The initial immunosuppressive treatment for children and young people with immune mediated glomerular diseases

Clinical Practice Guideline: The initial immunosuppressive treatment for children and young people with immune mediated glomerular diseases - UK Kidney Association

Aims and objectives:
The primary aim of the clinical practice recommendation is to create a united, paediatric-specific clinical approach for immune mediated glomerular diseases (IM-GD) nationally that is aligned with existing international guidelines and the latest evidence. This will aspire to improve the quality of care and reduce unwarranted variation across the UK in the treatment administered to children and young people (CYP) with IM-GD through these agreed standard treatment plans.

The objectives of the programme of work were:
• To review existing practice to provide nationally and internationally accepted speciality guidelines.
• To systematically summarise the current evidence relating to the treatment of IM-GD in children and young people.

To generate and agree on best practice recommendations for the immunosuppressive treatment following confirmation of IM-GD diagnosis in children and young people with the primary aim at achieving disease remission (termed ‘induction treatment’) and long term immunosuppressive treatment aimed at consolidating disease remission (termed ‘consolidation treatment’) within the first 12 months following diagnosis.


Read full Guideline